Remedy Pharmaceuiticals

Remedy Pharmaceuticals Initiates Phase 2A Study of CIRARA™ in Spinal Cord Injury

NEW YORK–(BUSINESS WIRE)–Remedy Pharmaceuticals, a company focused on the development and commercialization of CIRARA™, a breakthrough drug for treating acute…